evipedia.ai
← Back

Vegan Diet for Health & Longevity

Created on 10/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

A vegan diet, an animal-free eating pattern for health and longevity, reliably lowers body weight, plaque-forming cholesterol and long-term blood sugar, most with excess weight, high cholesterol or diabetes; lifespan effects remain uncertain. Without supplements, vitamin B12 deficiency is common; iodine, calcium, vitamin D and fish-type omega-3 fats tend to run low, and two large studies found more hip fractures, weakening or disappearing with enough calcium and vitamin D. (Full Review)

Protocol

Healthy whole-food vegan pattern (Gardner, Stanford)
Minimal ultra-processed food
Vegetables, legumes, whole grains, nuts and seeds, as used in the twin trial
Core supplements
Vitamin B12 50 µg daily
Calcium of at least 525 mg/day from food or supplement; algal omega-3 adjusted toward an omega-3 index of 8% or more
Protein target for training
About 1.6 g/kg/day
Soy protein isolate topping up whole foods
Time to effect
Body weight
3–6 months
Mainly through lower energy density, usually without calorie counting
LDL cholesterol
Within 8 weeks
As seen in the twin trial
HbA1c
3–6 months
Largely through weight loss and better insulin sensitivity

Benefits

Contraindications
  • Pregnancy and lactation without supervised supplementation
  • Osteoporosis or prior fragility fracture with calcium below 525 mg/day (not studied in this group)
  • Underweight adults aged 80 or older (BMI below 18.5)
  • Current or past restrictive eating disorder (no controlled human data)
  • Advanced kidney disease with high potassium (eGFR below 30 mL/min/1.73 m²; no vegan-specific human data)
    •
Key Interactions
  • Insulin and sulfonylureas (e.g., glipizide): low-blood-sugar risk as glucose falls
  • Warfarin: shifts in vitamin K intake from leafy greens change clotting
  • Levothyroxine: soy protein taken with the dose reduced absorption
  • Iron supplements: absorption falls with tea, coffee, calcium and phytates
  • Potassium-sparing diuretics (e.g., spironolactone): high blood potassium risk, mainly with kidney impairment
    •
Theoretical (inferred from mechanism)
  • Antihypertensives (e.g., amlodipine): possible light-headedness on standing
  • ACE inhibitors and ARBs (e.g., lisinopril): high blood potassium possible, mainly with kidney impairment
  • Statins and ezetimibe (e.g., atorvastatin): lower-than-targeted LDL
  • Metformin: vitamin B12 deficiency and neuropathy possible
  • Acid suppressants, prescription and over-the-counter (proton pump inhibitors, e.g., omeprazole; histamine-2 blockers, e.g., famotidine): raised vitamin B12 deficiency odds after two or more years of use
  • Cholesterol- and glucose-lowering supplements (red yeast rice, berberine): possible low blood sugar when berberine is combined with diabetes drugs
    •

Risk & Side Effects

  • High:
  • Medium: Vitamin B12 deficiency, bone fractures, iodine deficiency, lower vitamin D status
    •
  • Low: Lower iron stores, lower zinc status, hemorrhagic stroke, depression, orthorexia symptoms
    •
  • Speculative: Low long-chain omega-3 status, muscle loss in older adults
    •

Monitoring

Marker Target Why
Serum vitamin B12 200–900 pg/mL Safety check: deficiency
Methylmalonic acid (MMA) Below 0.4 µmol/L Safety check: rises early in B12 deficiency
Homocysteine 5–15 µmol/L Safety check: rises with B12 deficiency
Ferritin 30–300 ng/mL Safety check: iron stores
Complete blood count Not specified in the ER Paired with ferritin
25-hydroxyvitamin D 30–100 ng/mL Safety check: supplementation and bone risk
TSH 0.4–4.0 mIU/L Safety check: rises with iodine deficiency
Urinary iodine 100–200 µg/L Nutrient put at risk
LDL cholesterol Below 100 mg/dL (2.6 mmol/L) for moderate-risk adults Expected to fall
Apolipoprotein B (apoB) Below 100 mg/dL for moderate-risk adults Expected to fall with LDL particle number
HbA1c 4.0–5.6% Expected to fall with improved glycemic control
Weight Not specified in the ER Expected to improve
Blood pressure Not specified in the ER Tracks drug adjustments
Glucose Not specified in the ER Tracks drug adjustments
Omega-3 index 8% or higher Safety check: algal oil dosing
Bone mineral density (DXA scan) No established target; change tracked from the individual's own baseline Safety check: calcium, vitamin D and protein intake

Cadence: Baseline before the switch; lipids, HbA1c and blood pressure at 8–12 weeks; vitamin B12 markers, ferritin, vitamin D and thyroid tests every 6–12 months; omega-3 index 3–4 months after starting algal oil; bone density every 2 years where bone risk exists

Qualitative Assessment

  • Energy levels and exercise recovery
  • Digestive comfort, including bloating in the first weeks
  • Satiety and hunger between meals
  • Signs of B12 deficiency such as tingling hands or feet, fatigue or memory lapses
  • Hair, skin and nail condition as rough nutrient-status signals
  • Mood and sustained satisfaction with the diet
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.